The COVID-19 pandemic has massively disrupted—and exhausted the shortcomings of—our health care systems (HCSs) nationally and around the world in both the public and private business sectors. But it has also served as a catalyst for needed transformation, pushing our HCSs to make significant changes far faster than they would have done in the pre-pandemic operating environment.
The challenge now is to build on the momentum from those efforts to deliver better care at lower overall cost and to build resilience for future waves of COVID-19—or even other potential pandemics. Public and private HCSs nationally and worldwide can do so by applying five lessons from their responses to the pandemic:
- Improve patient health outcomes by defining appropriate care for specific population segments.
- Implement new care models, realigning resources in order to rethink the way that health care is delivered.
- Apply digital solutions more widely.
- Revamp governance and policy to define shared goals and improve decision making.
- Adopt standardized data and analytics across a broader range of use cases.
Pre-pandemic Challenges
Even before the current crisis, our Health Care Services (HCSs) faced a variety of issues. Long-term trends, such as Non-Communicable Diseases (e.g., Obesity, Diabetes, High Blood Pressures) and more prevalent chronic diseases, have been increasing the demand for care. Costs have been rising at unsustainable rates, and patient outcomes differ widely. Many health care systems lagged in their adoption of data and analytics solutions; even as new technologies have continued to disrupt many industries.
COVID-19 compounded these challenges, but the end of the pandemic—whenever it comes—will not mean a return to the status quo. Given that projections call for health care spending to continue to grow steeply, our Health Care Services (HCSs) face increased financial pressure to bend the cost curve. What’s more, incremental changes will be insufficient. Instead, transformative change will be required, as called for by stakeholders including our Government agencies, players, and providers.
COVID-19 has had a mixed impact on our Health Care Services (HCSs’) ability to deliver on their three main objectives: improving population health, innovating in the delivery of care, and increasing their efficiency and effectiveness.
The COVID-19 pandemic has massively disrupted—and exhausted the shortcomings of—our health care systems (HCSs) nationally and around the world in both the public and private business sectors. But it has also served as a catalyst for needed transformation, pushing our HCSs to make significant changes far faster than they would have done in the pre-pandemic operating environment.
The challenge now is to build on the momentum from those efforts to deliver better care at lower overall cost and to build resilience for future waves of COVID-19—or even other potential pandemics. Public and private HCSs nationally and worldwide can do so by applying five lessons from their responses to the pandemic:
- Improve patient health outcomes by defining appropriate care for specific population segments.
- Implement new care models, realigning resources in order to rethink the way that health care is delivered.
- Apply digital solutions more widely.
- Revamp governance and policy to define shared goals and improve decision making.
- Adopt standardized data and analytics across a broader range of use cases.
Pre-pandemic Challenges
Even before the current crisis, our Health Care Services (HCSs) faced a variety of issues. Long-term trends, such as Non Communicable Diseases (e.g. Obesity, Diabetes, High Blood Pressures) and more prevalent chronic diseases, have been increasing the demand for care. Costs have been rising at unsustainable rates, and patient outcomes differ widely. Many health care systems lagged in their adoption of data and analytics solutions, even as new technologies have continued to disrupt many industries.
COVID-19 compounded these challenges, but the end of the pandemic—whenever it comes—will not mean a return to the status quo. Given that projections call for health care spending to continue to grow steeply, our Health Care Services (HCSs) face increased financial pressure to bend the cost curve. What’s more, incremental changes will be insufficient. Instead, transformative change will be required, as called for by stakeholders including our Government agencies, players, and providers.
COVID-19 has had a mixed impact on our Health Care Services (HCSs’) ability to deliver on their three main objectives: improving population health, innovating in the delivery of care, and increasing their efficiency and effectiveness. Improve population health. The pandemic has served as a kind of proving ground for our HCSs to implement rapid-response measures, allowing them to build up crucial experience in fast adaptation and innovation.
Innovate in the delivery of care. Many SADC countries strengthened their multidisciplinary collaboration to fight the pandemic. Eswatini and South Africa forged smart public-private partnerships (PPP) to tap into private-sector capacity and develop new digital tools.
Increase HCS efficiency and effectiveness. Many local and regional health care systems (HCSs) have shifted to more agile decision making and increased their adoption of data use cases. Eswatini and South Africa have been able to coordinate available beds and scarce resources by commissioning a government body to collect, analyze, and disseminate information from local health regions. Yet many other HCSs around the SADC region, both national and developing economies, have been unable to launch similar measures due to a lack of consistent, transparent, interoperable data.
Therefore, our Eswatini and SADC health care systems (HCSs) must capitalize on the lessons learned from their COVID-19 responses. In the short term, they should focus on fully implementing the innovations they have developed, such as streamlined decision making, site reconfiguration, and changes in collaborative working models. Our HCSs need to take the best of what worked and build that into a new, post-pandemic operating model, with the goal of delivering better patient outcomes at lower cost for every liSwati citizen.
In the medium to long term, our Eswatini and regional health care systems (HCSs) should reprioritize and accelerate transformations that were already underway before COVID-19 hit, disregarding initiatives that may no longer be relevant in a post-pandemic world. To build on the lessons and insights of the pandemic, Eswatini HCS leadership teams should take a hard look at the investments and plans that are in place and ongoing, and make adjustments based on what they have learned.
Furthermore, Eswatini health systems should build their organizational resilience for future crises—potentially subsequent waves of COVID-19 or another future pandemic.
According to our FESBC Health Economists, there are Five Lessons for our Health Care Systems. Hence, in order to build on their experience in responding to future pandemics, our Eswatini HCSs should focus on the following five lessons learned:
- Patients and Outcomes: First and foremost, our Eswatini health care systems (HCSs) need to focus on patients and outcomes as an overarching strategic objective that informs all other changes. When assessing the validity and value of specific changes, our HCS leadership teams should apply one metric: generating the biggest possible impact on the largest number of people at the lowest possible cost.
Other measures, such as population segmentation, are clearly valuable but require further refining. Many Eswatini HCSs segmented their populations to tailor prevention and care for specific groups. But they did not apply consistent segmentation criteria across our HCSs in order to facilitate comparisons and applied (compiled) learning. For example, some countries in the region segmented its population by age, some by risk profile, and others by clinical condition.
To overcome this challenge and ensure reliable, comparable clinical research results and coherent segmentation premises, an international consortium led by the World Health Organization was able to rapidly establish a consistent set of outcome measures to support COVID-19 research. And more recently, the International Consortium for Health Outcomes Measurement (ICHOM), in cooperation with more than 30 clinical experts and patients across 15 countries, developed a standard set of outcomes for COVID-19.
Leveraging these standardized data definitions for patient results across our HCSs will help our Eswatini HCSs and Allied Medical organizations to learn more quickly and adopt best practices nationally.
In the post-pandemic environment, our local health care systems (HCSs) should build on these lessons to incorporate population segmentation when designing effective social interventions. They should also focus on preventive care and self-empowerment among patients.
- Care Models and Resources. In order to combat future pandemics, our local Health Care Systems (HCSs) should adapt the way they deliver care, by implementing such best practices as cooperating through deep public-private partnerships (PPP), by combining clinical and social care, while taking other measures to realign care pathways, roles, sites, and services. Some of those changes will have clear repercussions beyond the pandemic in our Kingdom.
For example, the South African (HCSs) rapidly intervened to ensure that local hospitals and health systems would have the ability to handle a potential surge of COVID-19 patients by temporarily expanding capacity at care facilities and issuing regulatory waivers This approach also facilitated increased access to tele-health for South African Medicare patients to ensure that they could remain safely at home and still have access to physicians and other specialists.
Furthermore, South Africa reconfigured its care pathways during the pandemic as well, setting up COVID-19-free elective cancer hubs across inner Cities to continue delivering critical treatments and surgeries while converting nearly all outpatient interactions to virtual (on-line) settings.
New workforce models have also emerged. In Australia, pharmacists have been empowered to renew prescriptions for antibiotics and medications for chronic conditions. And cross-system supply chain networks have improved procurement for entire systems. The Netherlands centralized its supply of personal protective equipment through a supply chain control tower, increasing the ability to foresee potential shortages and delays and allowing leaders to redirect needed resources to facilities with the most urgent need.
After the pandemic, HCSs need to fully implement these positive changes and apply them in non-COVID situations. For example, new care models and pathways established during the crisis can be used to treat non-communicable diseases (NCDs) like Diabetes, Obesity and High Blood Pressure in the future. Specific care methodologies undertaken to protect the populations at the greatest risk of developing COVID-19, such as the deployment of self-empowerment digital tools for patients, could be leveraged for such vulnerable NCDs as well.
- Digital Care.During the pandemic, the demand for digital health care technologies has rapidly grown among both patients and physicians locally and regionally. In South Africa, for example, patients’ willingness to use Tele-health rose by up to 60 percentage points as compared to pre-pandemic levels. Additionally, a South African insurance company increased its portfolio of digital services by more than 200% in a matter of days.
Notably, the organizations that had a stronger foundation in terms of digital technology before the pandemic hit were far better equipped to respond to it. Other health systems that may not have had such an infrastructure in place before the coronavirus have taken noteworthy steps to close the gap. For example, our SADC region rolled out a Tele-health app that offers free voice and video consultations around the clock. And they announced a R 56 million (Rand) initiative in May for digital tools, including artificial intelligence.
It is unclear whether current adoption rates for digital tools, especially among patients, will remain at current levels once the immediate crisis is over. But even if they decline somewhat, they are unlikely to fall back to the levels of 2019. These new tools have already transformed care by making it more accessible and improving the patient experience at lower cost. Some estimates hold that digital solutions can increase outpatient productivity by more than 30%. A FESBC survey also found that Tele-consultation can reduce hospital admissions by 45%.
Therefore, our regional health care systems (HCSs) need to continue investing in and enabling solutions that allow them to manage subsequent waves of the pandemic or future pandemics. These measures include permanently removing the regulatory and financial barriers to adoption—or at least not reinstating those barriers after the pandemic has passed. More broadly, our SADC health care systems and Allied Medical organizations need to set clear digital strategies and investment plans to build resiliency and deliver efficiencies.
- Governance and Policy: Several countries that had survived epidemics, such as Ebola, SARS and MERS, had made changes to governance and decision making in light of their experiences. As a result, the health care systems (HCSs) in those countries have implemented contingency pandemic governance models for COVID-19 with greater agility and better coordination among stakeholders and government agencies.
For instance, after the 2015 MERS epidemic in South Korea, which has a government-run HCS, the country established an emergency operations centre. The centre monitors infectious diseases worldwide, respond to public health crises, distributes manpower and material resources, and conducts on-site epidemiological investigations through a multidisciplinary rapid-response team.
Therefore, the government’s unified response to COVID-19 led to high levels of public trust and cooperation in South Korea. Transparent communications, detailed public dashboards, early interventions, proactive acquisition of personal protective equipment (PPE), and a comprehensive digital solution to track citizen movements all led to significantly lower incidences of both cases and deaths.
Some other Western countries that did not have such a strong foundation in place before the pandemic were nevertheless able to rapidly shift in order to support new ways of working. In the UK, bureaucratic governance, highly autonomous regional and local health agencies, and a lack of pandemic experience initially hindered the response of the country’s national health system (NHS). But it quickly adapted its governance model.
The NHS rapidly reconfigured acute-care facilities across sites and centralized leadership, designating authority to one individual in order to simplify decision making, ensure agility, and enable those closest to the patients to make key decisions. Acute-care pathways were streamlined to maximize capacity. Hospitals coordinated with community care facilities to discharge patients to less acute settings, rehab facilities, or home more quickly—but with additional visits and oversight by health care providers. Referral criteria to treat non-urgent conditions were changed to reduce unwarranted demand for acute care.
Our Eswatini HCSs can build on that experience in revising our local HCSs governance and policy in the future. In particular, we should review our HCSs and Allied Medical organizational models in order to improve coordination and decision making. Our local HCSs also need to align incentives (e.g. attractive reward) to make sure that all relevant stakeholders make rational choices that lead to better national outcomes.
- Data and Analytics: In Africa our Health Care Systems (HCSs) faced a huge challenge in implementing data and analytics to inform and improve their mitigation measures. There is a clear need for clarity and standardization in such areas as interoperability, along with data infrastructure and definitions—starting with standard patient outcome definitions.
For example, even now, almost a year into the pandemic, very few HCSs in Africa collect, analyze, and report cases using both age, occupation and family history in order to understand underlying medical conditions. Such an analysis would support the development not only of measures to control the disease but also forward-looking research agendas.
For example, World renowned Health care Systems (HCSs) that had fewer problems in terms of interoperability and infrastructure, such as those in Taiwan, South Korea and Singapore, were able to respond both earlier and more effectively. Other HCSs, such as the UK’s NHS and Germany, were able to accelerate research by sharing data and collaborating in order to understand the disease progression of COVID-19 and thus update treatment protocols.
Notably, the fourth and fifth areas in our analysis—governance and policy, along with data and analytics—are interrelated. Governance entails setting up data collection processes and sharing policies, and the data is then used to generate insights that inform future governance.
In addition to overcoming the ever-present challenges of improving data standards, interoperability, and concerns about sharing data, our Eswatini Health Care Systems (HCSs) and allied medical organizations (e.g. Dental, Laboratory, Physiotherapy, etc) must take three actions to develop an effective data strategy: This according to our FESBC Health Economists
- Build the right health care organization and infrastructure nation-wide.Our Eswatini HCSsand allied medical organizations need to break down internal silos (isolated offices and departments) by creating cross-functional data teams, collaborating with external partners, and developing the right governance policies for how data can be used.
- Apply a wider set of tools across a range of use cases (e.g. case studies).Rather than focusing on individual pilot surveys with highly specific analytics tools, our HCSs and organizations should adopt more flexible data solutions that can be used in multiple areas and are highly interoperable with other solutions.
- Create a data-driven culture.Monitor data to drive operational improvements nationally, with transparent impact measures at all levels of decision making. Not all of the individual data elements necessary to control a pandemic will be known early on, but Eswatini HCSs with a strong data-driven culture will be better positioned to be flexible and adjust their analysis on critical patient outcome measures.
Even as our Eswatini and global health care systems (HCSs) continue to battle COVID-19, it’s possible to look ahead and imagine what health care could look like in the future. It may have the following according to our FESBC Health Economist:
- A much greater focus on prevention, with more consistent use of population segmentation.
- No more silos (isolated departments) that separate different components of the value chain, thus enabling greater collaboration for prioritized conditions or population segments.
- An increased use of digital solutions to give patients greater control over their own care—and empower policymakers and clinical staff to make data-driven, objective decisions.
- Application of all of the above improvements to non-communicable diseases, which account for the vast majority of health care spending, thus leading to better overall outcomes at lower costs.
- By applying the five lessons our FESBC Heath Economics Expert have identified, and by capitalizing on the lessons learned during their responses to COVID-19, our Health Care System (HCSs) can turn this vision into reality. To drive this transformation, our HCS leaders at all levels—across stakeholders and within departments—will need to develop their organizations’ capacities and specific capabilities to enable and sustain changes to their institutions and ways of working.
Discussion about this post